Celemics, Inc. (KOSDAQ:331920)
South Korea · Delayed Price · Currency is KRW 2,970.00
+85.00 (2.95%)
At close: Jan 30, 2026
Celemics Revenue
Celemics had revenue of 1.26B KRW in the quarter ending September 30, 2025, a decrease of -7.16%. This brings the company's revenue in the last twelve months to 6.13B, up 2.01% year-over-year. In the year 2024, Celemics had annual revenue of 6.72B with 2.15% growth.
Revenue (ttm)
6.13B
Revenue Growth
+2.01%
P/S Ratio
3.95
Revenue / Employee
153.32M
Employees
40
Market Cap
24.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.72B | 141.42M | 2.15% |
| Dec 31, 2023 | 6.58B | -2.15B | -24.65% |
| Dec 31, 2022 | 8.73B | 7.17B | 461.56% |
| Dec 31, 2016 | 1.55B | 812.79M | 109.60% |
| Dec 31, 2015 | 741.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 117.11B |
| Corentec | 106.14B |
| Sanigen Co. | 27.30B |
| Alpha AI | 25.98B |
| Bio Protech | 20.58B |
| Finemedix | 10.48B |
| Genolution | 9.15B |
| TASCOM | 5.53B |